mRNA-1273 Induces Stronger Response Than BNT162b2 for Immunosuppressed
For immunosuppressed patients, mRNA-1273 induces a stronger seroresponse than BNT162b2, according to a research letter published online.
COVID19 Vaccine
Antibody Response in Human Milk After mRNA- vs Vector-Based COVID-19 Vaccination
Researchers compared the antibody response in human milk among women who received COVID-19 mRNA-based vaccines vs vector-based vaccines.
COVID-19 mRNA-1273 Vaccine 50 µg Safe, Effective for Children Aged 6 to 11 Years
Two 50-µg doses of the mRNA-1273 vaccine are safe and effective for children aged 6 to 11 years, according to a study published online.
Frequency, Severity of Adverse Events in Older Adults After COVID-19 Vaccine Booster
Researchers surveyed older adults to determine the frequency and severity of adverse events following receipt of a COVID-19 vaccine booster dose.
FDA Limits Use of J&J COVID-19 Vaccine Due to Blood Clot Risk
The U.S. Food and Drug Administration on Thursday greatly restricted the recommended use of the Johnson & Johnson COVID-19 vaccine.
Risk for Guillain-Barré Syndrome Increased After Ad.26.COV2.S Vaccination
The incidence of Guillain-Barré syndrome is increased after Ad.26.COV2.S vaccination, but incidence is not increased after mRNA vaccination.
Pfizer Seeks FDA Approval of COVID-19 Boosters for Children Ages 5 to 11
Pfizer Inc. announced Tuesday that it has asked the U.S. FDA to approve emergency use of its booster shot for children ages 5 to 11 years.
Myocarditis, Pericarditis Risk Highest After Second COVID-19 Vaccine Dose
The risk for myocarditis and pericarditis after COVID-19 mRNA vaccines is highest in young men after the second vaccine dose.
Robust Immunity After COVID-19 Vaccination in People With HIV With High CD4 Count
Researchers assessed the relationship between current CD4 T-cell counts and Immunogenicity after COVID-19 vaccination among people with HIV infection.
Vaccination Reduces Severe COVID-19 Risk in Heart Transplant Patients
Among orthotopic heart transplant recipients, COVID-19 vaccination is associated with fewer COVID-19 infections, hospitalizations, and deaths and no heart transplant-specific adverse events.
- Loading...
Loading...
Next post in COVID19
Loading... 
Loading...